发明名称 Circulating insulin-like growth factor-I and prostate cancer risk
摘要 Methods of predicting a propensity to developing prostate cancer are presented. The method consists of measuring the IGF status of individual. Individuals with high IGF status, as compared with normal reference range values, are at increased risk for developing prostate cancer. More particularly, the IGF status may be determined by measuring IGF-I levels and/or IGFBP-3 levels. High IGF and low IGFBP levels are indicative of a high IGF status. A method of determining the prognosis of existing prostate cancers or of monitoring disease progression involves determining the IGF/PSA status of an individual. Individuals with a high IGF/PSA status (both high IGF status and high PSA levels) tend to develop severe prostate cancer and have a poorer overall prognosis.
申请公布号 US2003044860(A1) 申请公布日期 2003.03.06
申请号 US20010025350 申请日期 2001.12.18
申请人 LADY DAVIS INSTITUTE 发明人 POLLAK MICHAEL N.;STAMPFER MEIR J.;GIOVANNUCCI EDWARD
分类号 A61K38/00;G01N33/574;G01N33/68;G01N33/74;(IPC1-7):G01N33/574;G06F19/00 主分类号 A61K38/00
代理机构 代理人
主权项
地址